Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 57801-57850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04329364
RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty
PHASE2/PHASE3Recruiting
128 participants
Started: Oct 1, 2020 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06199856
Assessment System for Sarcopenia Based on Ultrasonographic Data
N/ARecruiting
1,500 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT04912739
Targeted Health Dialogues in Primary Care
N/ARecruiting
18,000 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2040
5 conditions1 sponsor1 location
NCT04458649
Continuous Glucose Monitoring in Infants
N/ARecruiting
200 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05286983
Multidimensional Assessment of Infant, Parent and Staff Outcomes During a Family Centered Care Enhancement Project
N/ARecruiting
495 participants
Started: Oct 1, 2020 · Completed: Jul 1, 2026
1 condition2 sponsors2 locations
NCT04481815
Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
PHASE2Recruiting
240 participants
Started: Oct 1, 2020 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03940521
Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment
N/ARecruiting
48 participants
Started: Sep 30, 2020 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04473196
The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion
NARecruiting
92 participants
Started: Sep 30, 2020 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT04398628
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
N/ARecruiting
3,000 participants
Started: Sep 30, 2020 · Completed: Dec 31, 2035
13 conditions8 sponsors73 locations
NCT04742621
Liver Transplantation for Unresectable Liver Limited Colorectal Metastases
N/ARecruiting
20 participants
Started: Sep 30, 2020 · Completed: Jul 27, 2035
1 condition1 sponsor1 location
NCT04874220
Neural Correlates of Real World Spatial Navigation in Humans
NARecruiting
70 participants
Started: Sep 30, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04175431
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
PHASE2Recruiting
100 participants
Started: Sep 30, 2020 · Completed: Jul 1, 2031
1 condition2 sponsors2 locations
NCT04535713
GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
PHASE2Recruiting
260 participants
Started: Sep 30, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05544266
Rare and Atypical Diabetes Network
N/ARecruiting
2,000 participants
Started: Sep 30, 2020 · Completed: Sep 30, 2030
7 conditions2 sponsors13 locations
NCT04498598
Structural Modification In Supraglottic Airway Device
NARecruiting
100 participants
Started: Sep 30, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04495088
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
PHASE3Recruiting
818 participants
Started: Sep 30, 2020 · Completed: Aug 31, 2030
1 condition4 sponsors1 location
NCT05089331
ROSE-Longitudinal Assessment With Neuroimaging
N/ARecruiting
250 participants
Started: Sep 30, 2020 · Completed: Jun 1, 2026
1 condition8 sponsors7 locations
NCT05130658
Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training
NARecruiting
30 participants
Started: Sep 30, 2020 · Completed: Sep 29, 2024
1 condition1 sponsor1 location
NCT05037682
Pain and Opioid Management in Older Adults
NARecruiting
1,035 participants
Started: Sep 30, 2020 · Completed: Sep 30, 2024
2 conditions2 sponsors1 location
NCT04617717
Personalized Treatment for Patients With Premature Ventricular Beats
N/ARecruiting
224 participants
Started: Sep 30, 2020 · Completed: Jul 31, 2040
1 condition2 sponsors1 location
NCT06290297
Assessment and Telerehabilitation of Cognitive and Motor Skills in Children With Neurodevelopmental Disabilities (Tablet Project)
NARecruiting
350 participants
Started: Sep 30, 2020 · Completed: Jun 30, 2024
1 condition13 sponsors1 location
NCT03957954
Stem Cell Therapy for Limbal Stem Cell Deficiency
PHASE1Recruiting
20 participants
Started: Sep 30, 2020 · Completed: Apr 30, 2027
1 condition3 sponsors1 location
NCT05778500
Algorithms to Improve the Accuracy of the Echocardiographic Report
N/ARecruiting
3,500 participants
Started: Sep 30, 2020 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04572269
Metabolomics of Obstructive Sleep Apnea
N/ARecruiting
1,000 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06709326
APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer
NARecruiting
130 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04317820
Deep Brain Reorienting in Post-traumatic Stress Disorder
NARecruiting
214 participants
Started: Sep 29, 2020 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06116396
Liquid Biospy for Urinary Cancers
N/ARecruiting
450 participants
Started: Sep 29, 2020 · Completed: Sep 29, 2028
1 condition1 sponsor1 location
NCT05458037
RCT of Pain Perception With Fast and Slow Tenaculum Application
NARecruiting
150 participants
Started: Sep 29, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04422912
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
PHASE1Recruiting
55 participants
Started: Sep 29, 2020 · Completed: Jan 31, 2029
1 condition1 sponsor13 locations
NCT04577014
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
PHASE1/PHASE2Recruiting
98 participants
Started: Sep 29, 2020 · Completed: Sep 29, 2026
4 conditions2 sponsors1 location
NCT04365855
The Olmsted NAFLD Epidemiology Study (TONES)
NARecruiting
800 participants
Started: Sep 29, 2020 · Completed: Jun 30, 2028
2 conditions1 sponsor1 location
NCT04400695
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
PHASE3Recruiting
366 participants
Started: Sep 29, 2020 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04405700
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
N/ARecruiting
2,800 participants
Started: Sep 29, 2020 · Completed: May 31, 2026
4 conditions1 sponsor1 location
NCT04666727
Role of Diet on the Microbiome of the Digestive System
N/ARecruiting
30 participants
Started: Sep 29, 2020 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04317664
Intervention to Improve Driving Practices Among High-Risk Teen Drivers
PHASE3Recruiting
480 participants
Started: Sep 28, 2020 · Completed: Dec 15, 2025
4 conditions4 sponsors1 location
NCT04533958
Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy
NARecruiting
60 participants
Started: Sep 28, 2020 · Completed: Feb 28, 2027
1 condition1 sponsor6 locations
NCT07186010
Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
N/ARecruiting
50 participants
Started: Sep 28, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04579835
Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
N/ARecruiting
45 participants
Started: Sep 28, 2020 · Completed: Sep 28, 2026
2 conditions1 sponsor1 location
NCT06387498
Testicular Tissue Cryopreservation (TTC)
NARecruiting
60 participants
Started: Sep 28, 2020 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT04444869
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
PHASE2Recruiting
28 participants
Started: Sep 28, 2020 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT04450628
Esophagogastric Junction Distensibility During Hiatal Hernia Repair
NARecruiting
50 participants
Started: Sep 28, 2020 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT04156061
Effect of the SCOT-HEART 2 Trial on Lifestyle.
NARecruiting
400 participants
Started: Sep 28, 2020 · Completed: Jul 7, 2027
2 conditions3 sponsors1 location
NCT04494672
A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
NARecruiting
96 participants
Started: Sep 28, 2020 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT04564521
Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.
NARecruiting
36 participants
Started: Sep 28, 2020 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04501120
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
PHASE1/PHASE2Recruiting
458 participants
Started: Sep 28, 2020 · Completed: Sep 30, 2029
2 conditions2 sponsors12 locations
NCT04639297
NeuroVision vs Standard Neuromonitoring
NARecruiting
148 participants
Started: Sep 28, 2020 · Completed: Jun 20, 2027
1 condition1 sponsor1 location
NCT04688411
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NARecruiting
40 participants
Started: Sep 28, 2020 · Completed: Feb 1, 2025
4 conditions2 sponsors1 location
NCT04685226
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
310 participants
Started: Sep 27, 2020 · Completed: Feb 25, 2028
1 condition1 sponsor24 locations
NCT04333706
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
PHASE1/PHASE2Recruiting
65 participants
Started: Sep 26, 2020 · Completed: Sep 1, 2027
5 conditions2 sponsors3 locations
NCT04738162
Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
PHASE2Recruiting
80 participants
Started: Sep 25, 2020 · Completed: Jun 30, 2025
1 condition3 sponsors7 locations